Literature DB >> 19376273

Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology.

Xin Liu1, Juan Cheng, Xinchuang Zheng, Yiguo Chen, Chong Wu, Bin Li, Jianfeng Fu, Hongwei Cao, Yongling Lu, Jun Li, Jiang Zheng, Hong Zhou.   

Abstract

Bacterial DNA/CpG DNA is recognized as a key molecule during the pathogenesis of sepsis. Therefore, preventing CpG DNA from binding to its receptor is considered as the most promising strategy. In the present experiments, Radix et Rhizoma Rhei had the highest CpG DNA-binding ability among the seventy-eight traditional Chinese herbs. After the isolation of silica gel chromatography and high performance liquid chromatography (HPLC) and evaluation with affinity biosensor, the active fraction was confirmed and named Fraction D. It was found that in vitro, Fraction D bound to both CpG DNA and lipid A with high affinity, and strongly inhibited LPS- and CpG DNA-induced TNF-alpha release from RAW264.7 cells in a dose-dependent manner. Furthermore, Fraction D reduced the expression of TLR9 mRNA up-regulated by CpG DNA. In vivo, Fraction D protected mice challenged with lethal heat-killed E. coli. Using HPLC method, two monomers with high affinity for CpG DNA were isolated and identified as rhein and emodin. Rhein could significantly reduce CpG DNA- and LPS-induced TNF-alpha release, but emodin only reduced CpG DNA-induced TNF-alpha release. Rhein in combination with emodin could play synergistic inhibitory effect on both CpG DNA and LPS-induced TNF-alpha release, which contributed to the bioactivity of Fraction D. In conclusion, we successfully established the platform to screen anti-CpG DNA components of traditional Chinese herbs using affinity biosensor technology, got active Fraction D from Radix et Rhizoma Rhei and determined rhein and emodin as the main bioactive ingredients in Fraction D.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376273     DOI: 10.1016/j.intimp.2009.03.023

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity.

Authors:  Xichun Pan; Junjie Yue; Guofu Ding; Bin Li; Xin Liu; Xinchuan Zheng; Mengchen Yu; Jun Li; Weiwei Jiang; Chong Wu; Jiang Zheng; Hong Zhou
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 2.  Modulation of Toll-like receptor signaling in innate immunity by natural products.

Authors:  Luxi Chen; Jianhua Yu
Journal:  Int Immunopharmacol       Date:  2016-02-15       Impact factor: 4.932

3.  Kukoamine B, a novel dual inhibitor of LPS and CpG DNA, is a potential candidate for sepsis treatment.

Authors:  Xin Liu; Xinchuan Zheng; Ning Wang; Hongwei Cao; Yongling Lu; Yupeng Long; Kecen Zhao; Hong Zhou; Jiang Zheng
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

4.  Inhibition of endotoxin-induced airway epithelial cell injury by a novel family of pyrrol derivates.

Authors:  Nuria E Cabrera-Benítez; Eduardo Pérez-Roth; Ángela Ramos-Nuez; Ithaisa Sologuren; José M Padrón; Arthur S Slutsky; Jesús Villar
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

5.  Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model.

Authors:  Nuria E Cabrera-Benitez; Eduardo Pérez-Roth; Milena Casula; Angela Ramos-Nuez; Carla Ríos-Luci; Carlos Rodríguez-Gallego; Ithaisa Sologuren; Virginija Jakubkiene; Arthur S Slutsky; José M Padrón; Jesús Villar
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

Review 6.  Rhein: A Review of Pharmacological Activities.

Authors:  Yan-Xi Zhou; Wei Xia; Wei Yue; Cheng Peng; Khalid Rahman; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-22       Impact factor: 2.629

7.  A novel role of kukoamine B: Inhibition of the inflammatory response in the livers of lipopolysaccharide-induced septic mice via its unique property of combining with lipopolysaccharide.

Authors:  Wei-Ting Qin; Xu Wang; Wei-Chang Shen; Bing-Wei Sun
Journal:  Exp Ther Med       Date:  2015-01-19       Impact factor: 2.447

8.  Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients.

Authors:  Huanhuan Wang; Xiaoyun Hu; Teng Wang; Cheng Cui; Ji Jiang; Kai Dong; Shuai Chen; Chunyan Jin; Qian Zhao; Bin Du; Pei Hu
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

9.  Antibiotic Isoflavonoids, Anthraquinones, and Pterocarpanoids from Pigeon Pea (Cajanus cajan L.) Seeds against Multidrug-Resistant Staphylococcus aureus.

Authors:  Lex Aliko P Balida; Julia Theresa A Regalado; Jade Joshua R Teodosio; Kathryn Ann H Dizon; Zhe Sun; Zhao Qi Zhan; Jenny Marie D Blancaflor; Jan Vincent N Sollesta; Zenith M Villorente; Jonel P Saludes; Doralyn S Dalisay
Journal:  Metabolites       Date:  2022-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.